IACH Journal Club-Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial – Monday, March 24, 2025 CME credits / Adam Barkay Open to access this content IACH Journal Club-Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial – Monday, March 24, 2025 Read More »
Hottest Myeloma Topics: Disease Outcome, MRD, Mass Spectrometry and Beyond – An IACH Round Table Discussion CME credits, Free / Adam Barkay Open to access this content Hottest Myeloma Topics: Disease Outcome, MRD, Mass Spectrometry and Beyond – An IACH Round Table Discussion Read More »
